This startup provides molecular diagnostic and laboratory services that utilize a bench-to-bedside approach to enhance the efficiency and accessibility of molecular testing. By enabling early disease detection through precise diagnostic tools, the company aims to reduce disease mortality and adverse drug reactions in patients.